Perspective and the measurement of costs and benefits for cost-effectiveness analysis in schizophrenia.
Perspective and the measurement of costs and benefits for cost-effectiveness analysis in schizophrenia. J Clin Psychiatry. 1999; 60 Suppl 3:32-5; discussion 36-7.